0,987  0,002  Chemoprotective
0,980  0,004  Alpha-glucosidase inhibitor
0,967  0,001  Antimutagenic
0,955  0,002  Monophenol monooxygenase inhibitor
0,951  0,002  Chemopreventive
0,944  0,003  Antioxidant
0,933  0,001  Amylase inhibitor
0,927  0,002  UGT1A9 substrate
0,925  0,002  NOS2 expression inhibitor
0,918  0,004  Mutagenic
0,915  0,002  Antihypoxic
0,913  0,003  Caspase 9 stimulant
0,911  0,002  Xanthine oxidase inhibitor
0,910  0,003  Free radical scavenger
0,905  0,003  Genotoxic
0,900  0,002  Proliferative diseases treatment
0,894  0,003  Cardioprotectant
0,888  0,007  Transcription factor NF kappa B inhibitor
0,875  0,005  Cyclophilin D inhibitor
0,875  0,005  Antidiabetic
0,871  0,002  UGT1A1 substrate
0,866  0,002  Sulfotransferase substrate
0,869  0,007  Antiinflammatory
0,864  0,009  Apoptosis agonist
0,856  0,003  Vasodilator, coronary
0,856  0,004  Antihypercholesterolemic
0,854  0,005  Carcinogenic
0,850  0,006  TNF expression inhibitor
0,844  0,004  Radioprotector
0,840  0,001  Antihemorrhagic
0,834  0,002  Melanin inhibitor
0,831  0,004  Cytostatic
0,823  0,002  Mediator release inhibitor
0,809  0,002  Carbonic anhydrase XIII inhibitor
0,802  0,002  Cystathionine beta-synthase inhibitor
0,775  0,004  Hypoglycemic
0,775  0,004  Nitric oxide antagonist
0,765  0,004  NOS3 expression inhibitor
0,764  0,004  UDP-glucuronosyltransferase substrate
0,762  0,004  Vascular (periferal) disease treatment
0,761  0,004  DNA damaging
0,754  0,004  AR expression inhibitor
0,751  0,004  Angiogenesis stimulant
0,746  0,005  Caspase 3 stimulant
0,753  0,012  Teratogen
0,742  0,006  Antibacterial
0,733  0,005  Amyloid beta aggregation inhibitor
0,733  0,004  Apoptosis antagonist
0,725  0,005  Hepatic disorders treatment
0,718  0,004  Hepatoprotectant
0,715  0,005  UGT1A6 substrate
0,705  0,004  Skin whitener
0,705  0,005  Antiamyloidogenic
0,714  0,014  Embryotoxic
0,700  0,008  Antithrombotic
0,693  0,004  Antihypertriglyceridemic
0,688  0,005  Tumour necrosis factor alpha release inhibitor
0,696  0,013  CYP2C9 substrate
0,679  0,015  Antileukemic
0,668  0,004  NOS3 expression enhancer
0,666  0,005  Antipruritic, allergic
0,661  0,022  CYP3A4 substrate
0,638  0,013  Immunostimulant
0,630  0,009  Antiparasitic
0,629  0,012  5 Hydroxytryptamine release stimulant
0,619  0,005  Antineoplastic (osteosarcoma)
0,606  0,010  Histamine release inhibitor
0,600  0,006  Antihelmintic
0,618  0,032  Antineoplastic (breast cancer)
0,598  0,014  CYP2C19 substrate
0,612  0,029  Antineoplastic (lung cancer)
0,589  0,013  Cytotoxic
0,581  0,006  RNA-directed DNA polymerase inhibitor
0,576  0,004  UGT2B4 substrate
0,565  0,003  Protein kinase stimulant
0,586  0,026  Alzheimer's disease treatment
0,570  0,016  5 Hydroxytryptamine release inhibitor
0,554  0,004  Lipid peroxidase inhibitor
0,541  0,003  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,551  0,014  Antifungal
0,543  0,006  ICAM1 expression inhibitor
0,545  0,009  Vasodilator
0,553  0,018  Spasmolytic
0,539  0,005  Non-steroidal antiinflammatory agent
0,533  0,003  Beta glucuronidase inhibitor
0,533  0,005  Antihypotensive
0,531  0,003  AMP-activated protein kinase stimulant
0,529  0,004  Antitussive
0,530  0,005  Radiosensitizer
0,528  0,006  Topoisomerase II inhibitor
0,539  0,018  Antineoplastic (cervical cancer)
0,525  0,004  Antidote
0,529  0,012  Hypoxia-inducible factor 1 alpha inhibitor
0,530  0,014  Antiprotozoal (Leishmania)
0,511  0,004  Carcinogenic, group 1
0,512  0,004  Hemostatic
0,513  0,007  Antineoplastic (small cell lung cancer)
0,522  0,021  Sensitization
0,502  0,002  Nitric-oxide synthase stimulant
0,522  0,026  Respiratory analeptic
0,524  0,029  Cholesterol antagonist
0,522  0,028  Prostate cancer treatment
0,496  0,004  UGT2B15 substrate
0,509  0,021  Analeptic
0,484  0,005  Alkylator
0,479  0,004  Neurotrophic factor enhancer
0,493  0,022  Antineoplastic (pancreatic cancer)
0,482  0,014  Antidiabetic symptomatic
0,473  0,006  VCAM1 expression inhibitor
0,468  0,003  Antihelmintic (Trematoda)
0,497  0,034  Immunosuppressant
0,463  0,003  DNA repair enzyme inhibitor
0,481  0,023  Antiosteoporotic
0,495  0,036  Antineoplastic (colorectal cancer)
0,487  0,030  Bone diseases treatment
0,461  0,004  Aldose reductase substrate
0,479  0,028  Ulceration
0,480  0,033  Stroke treatment
0,461  0,014  Interleukin 2 agonist
0,451  0,010  Antiviral (Herpes)
0,457  0,017  DNA synthesis inhibitor
0,449  0,008  Platelet adhesion inhibitor
0,449  0,012  Antineoplastic (sarcoma)
0,462  0,029  Antineoplastic (melanoma)
0,450  0,019  Antineoplastic (lymphoma)
0,430  0,004  Carbonic anhydrase III inhibitor
0,457  0,033  Antineoplastic (ovarian cancer)
0,430  0,008  Antiviral (Influenza)
0,425  0,005  Topoisomerase I inhibitor
0,448  0,028  Antineoplastic (brain cancer)
0,420  0,005  UDP-glucose 4-epimerase inhibitor
0,452  0,041  Antineoplastic (colon cancer)
0,414  0,003  Selectin antagonist
0,414  0,005  Aldehyde dehydrogenase inhibitor
0,418  0,010  Antineoplastic (squamous cell carcinoma)
0,411  0,003  Antiviral (Influenza B)
0,410  0,005  NADPH oxidase inhibitor
0,408  0,010  Interferon gamma antagonist
0,400  0,004  Aldose reductase inhibitor
0,431  0,036  Immunomodulator
0,399  0,005  Psychosexual dysfunction treatment
0,420  0,027  Antidiabetic (type 2)
0,397  0,005  Expectorant
0,396  0,006  Glutathione S-transferase substrate
0,409  0,020  Myocardial infarction treatment
0,393  0,005  Topoisomerase II alpha inhibitor
0,411  0,026  Antipyretic
0,405  0,022  Antineoplastic (liver cancer)
0,392  0,018  Cyclic AMP phosphodiesterase inhibitor
0,377  0,004  Carbonic anhydrase VI inhibitor
0,405  0,039  CYP1A2 substrate
0,384  0,018  P-glycoprotein inhibitor
0,401  0,036  Antineoplastic (glioma)
0,372  0,010  Alpha-N-acetylglucosaminidase inhibitor
0,377  0,023  Antineoplastic enhancer
0,431  0,079  Antiarthritic
0,384  0,044  Antiischemic
0,344  0,006  Interleukin 4 antagonist
0,348  0,011  Antiviral (Influenza A)
0,377  0,042  CTGF expression inhibitor
0,341  0,007  Antifungal enhancer
0,349  0,017  DNA methylase inhibitor
0,336  0,008  Antineoplastic antibiotic
0,335  0,007  Hexokinase inhibitor
0,365  0,040  Antineoplastic (non-small cell lung cancer)
0,371  0,049  Antimycobacterial
0,338  0,023  Antiviral (HIV)
0,330  0,017  DNA methyltransferase I inhibitor
0,353  0,041  Antineoplastic (multiple myeloma)
0,328  0,016  Peptidyltransferase inhibitor
0,318  0,008  Gout treatment
0,341  0,031  Antiulcerative
0,353  0,052  Lipoprotein disorders treatment
0,319  0,018  UGT1A3 substrate
0,305  0,005  Mannose-6-phosphate isomerase inhibitor
0,316  0,016  Antineoplastic (gastric cancer)
0,327  0,028  Septic shock treatment
0,336  0,038  Antineoplastic (glioblastoma multiforme)
0,315  0,020  Antineoplastic (carcinoma)
0,308  0,012  Acute respiratory distress syndrome (ARDS) treatment
0,305  0,012  Insulin secretagoues
0,294  0,004  Antiviral (Ebola)
0,293  0,006  Cyclooxygenase 3 inhibitor
0,291  0,007  Dementia treatment
0,288  0,007  Vascular dementia treatment
0,283  0,007  NADH dehydrogenase inhibitor
0,300  0,026  UGT2B7 substrate
0,294  0,023  Antipruritic, non-allergic
0,275  0,005  Photosensitizer
0,272  0,004  Histone deacetylase SIRT1 stimulant
0,272  0,004  Histone deacetylase stimulant
0,274  0,006  Alcohol dehydrogenase inhibitor
0,309  0,044  Interleukin agonist
0,280  0,015  Alkaline phosphatase inhibitor
0,281  0,018  Interleukin 6 antagonist
0,285  0,026  Thrombolytic
0,270  0,013  SULT1A3 substrate
0,364  0,107  Calcium channel L-type activator
0,268  0,017  Acetylcholinesterase inhibitor
0,252  0,007  Triose-phosphate isomerase inhibitor
0,250  0,005  Interleukin 12 antagonist
0,255  0,016  Chelator
0,246  0,009  Choleretic
0,246  0,014  ATPase inhibitor
0,362  0,130  Antineoplastic (solid tumors)
0,247  0,016  Cell wall synthesis inhibitor
0,239  0,008  Uric acid excretion stimulant
0,231  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,279  0,052  Antineoplastic (lymphocytic leukemia)
0,243  0,018  DNA polymerase I inhibitor
0,244  0,021  Antidiarrheal
0,227  0,004  Carbonic anhydrase VII inhibitor
0,327  0,105  Antiprotozoal
0,303  0,080  CYP2D6 substrate
0,228  0,010  Antibiotic
0,217  0,004  Fatty acid synthase inhibitor
0,216  0,005  Toll-Like receptor 4 antagonist
0,221  0,011  Antineoplastic, alkylator
0,215  0,007  Thioredoxin inhibitor
0,217  0,010  Phosphofructokinase-1 inhibitor
0,259  0,059  Pyruvate kinase inhibitor
0,209  0,009  HIV-1 integrase (Strand Transfer) inhibitor
0,268  0,069  Antineoplastic (renal cancer)
0,203  0,004  Antibiotic Glycopeptide-like
0,206  0,009  Multidrug resistance-associated protein 1 inhibitor
0,212  0,016  Antifungal (Cryptococcus)
0,204  0,009  HIV-1 integrase (3'-Processing) inhibitor
0,200  0,010  Carcinogenic, group 2A
0,201  0,012  Gastritis treatment
0,212  0,023  DNA intercalator
0,196  0,014  Antispirochetal
0,191  0,010  Transcription factor NF kappa B stimulant
0,233  0,056  Wound healing agent
0,186  0,009  Heat shock protein 70 antagonist
0,245  0,070  Hypolipemic
0,232  0,058  Antialcoholic
0,194  0,023  Retinoprotector
0,221  0,051  Dual specificity phosphatase 3 inhibitor
0,214  0,045  Antihelmintic (Nematodes)
0,202  0,038  Antineoplastic (bone cancer)
0,168  0,005  Carbonic anhydrase XIV inhibitor
0,250  0,087  CYP1A2 inhibitor
0,167  0,006  Neuraminidase (influenza) inhibitor
0,171  0,010  Carbonic anhydrase XII inhibitor
0,180  0,020  UGT2B1 substrate
0,179  0,023  Anticataract
0,160  0,004  Na+ K+ transporting ATPase inhibitor
0,171  0,017  Creatine kinase inhibitor
0,161  0,007  Phosphodiesterase 6D inhibitor
0,199  0,045  Muscular dystrophy treatment
0,196  0,043  Antirickettsial
0,200  0,047  Protein-tyrosine phosphatase inhibitor
0,212  0,062  Insulin sensitizer
0,155  0,007  Xanthine dehydrogenase inhibitor
0,229  0,082  Platelet antagonist
0,192  0,045  Cyclooxygenase inhibitor
0,267  0,123  Antineoplastic (endocrine cancer)
0,153  0,011  Estrogen agonist
0,168  0,028  SULT1A1 substrate
0,189  0,049  Hair growth stimulant
0,181  0,042  Antiprotozoal (Coccidial)
0,177  0,039  CF transmembrane conductance regulator agonist
0,163  0,025  Mucolytic
0,213  0,077  Interleukin antagonist
0,169  0,035  Cell adhesion inhibitor
0,143  0,009  Antiviral (Dengue virus)
0,177  0,044  Carcinogenic, group 3
0,155  0,023  Chronic obstructive bronchitis treatment
0,169  0,037  Antiviral (Hepatitis B)
0,230  0,099  Antineoplastic (bladder cancer)
0,191  0,060  Dual specificity phosphatase inhibitor
0,171  0,041  Cyclooxygenase 2 inhibitor
0,192  0,065  Antiviral (Hepatitis)
0,134  0,008  Neuraminidase inhibitor
0,141  0,014  CDC25A inhibitor
0,291  0,166  DNA directed DNA polymerase inhibitor
0,185  0,061  Liver fibrosis treatment
0,178  0,057  Cholinergic
0,195  0,075  Sedative
0,145  0,025  Estrogen antagonist
0,152  0,032  Antineoplastic (uterine cancer)
0,122  0,003  Arginase inhibitor
0,158  0,040  Antibacterial (Helicobacter pylori)
0,119  0,002  Sodium/glucose cotransporter 2 inhibitor
0,119  0,002  Sodium/glucose cotransporter inhibitor
0,121  0,005  Alpha-mannosidase inhibitor
0,127  0,013  HIV-1 integrase inhibitor
0,133  0,022  SULT1E1 substrate
0,126  0,015  Thioredoxin reductase inhibitor
0,115  0,005  Mannosidase inhibitor
0,142  0,035  HDL-cholesterol increasing
0,124  0,017  ATPase (Vacuolar H+) inhibitor
0,114  0,009  Antimycoplasmal
0,151  0,045  Protein-tyrosine phosphatase 1B inhibitor
0,117  0,013  Phosphodiesterase VI inhibitor
0,179  0,075  Diabetic retinopathy treatment
0,113  0,012  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,105  0,004  Glucose-6-phosphate isomerase inhibitor
0,107  0,008  Topoisomerase II beta inhibitor
0,116  0,019  Interferon agonist
0,165  0,071  Peroxidase inhibitor
0,122  0,028  NAD(P)H dehydrogenase (quinone) inhibitor
0,107  0,014  Maillard reaction inhibitor
0,096  0,003  Antibiotic Aminoglycoside-like
0,117  0,026  Interleukin 5 antagonist
0,093  0,003  Sodium/glucose cotransporter 1 inhibitor
0,127  0,037  Sphingomyelinase inhibitor
0,103  0,012  Protein 50S ribosomal subunit inhibitor
0,090  0,003  Cholesterol absorption inhibitor
0,109  0,023  Lipase inhibitor
0,102  0,017  Postmenopausal disorders treatment
0,229  0,145  Vasodilator, peripheral
0,141  0,059  Toll-Like receptor 2 antagonist
0,084  0,004  Protein 30S ribosomal subunit inhibitor
0,188  0,109  Aryl hydrocarbon receptor agonist
0,083  0,006  Heparanase inhibitor
0,146  0,069  Adenylate cyclase stimulant
0,081  0,005  Neuraminidase (Influenza A) inhibitor
0,095  0,018  Protein kinase C eta inhibitor
0,085  0,009  Glucose-6-phosphate translocase inhibitor
0,114  0,039  Estrogen receptor beta antagonist
0,100  0,025  T cell inhibitor
0,089  0,017  Interferon inducer
0,110  0,039  Arylamine N-Acetyltransferase substrate
0,097  0,027  Narcotic antagonist
0,166  0,098  Anesthetic general
0,091  0,024  Antitreponemal
0,218  0,156  GST M1-1 substrate
0,153  0,094  UGT2B10 substrate
0,107  0,048  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,115  0,057  Carcinogenic, group 2B
0,103  0,046  Antiviral (Rhinovirus)
0,107  0,051  Falcipain inhibitor
0,105  0,049  Falcipain 2 inhibitor
0,126  0,074  Cyclooxygenase 1 inhibitor
0,072  0,019  Phosphorylase inhibitor
0,142  0,092  UGT1A4 substrate
0,076  0,026  Nitric oxide donor
0,233  0,183  Atherosclerosis treatment
0,089  0,039  Telomerase inhibitor
0,103  0,054  UGT2B11 substrate
0,097  0,049  Restless leg syndrome treatment
0,064  0,017  Adenosine deaminase inhibitor
0,061  0,017  Equilibrative nucleoside transport protein inhibitor
0,222  0,181  GABA C receptor rho-3 antagonist
0,115  0,075  Growth stimulant
0,183  0,143  Huntington's disease treatment
0,073  0,035  CDC25B inhibitor
0,046  0,010  Nucleoside transporters inhibitor
0,057  0,021  Factor III inhibitor
0,181  0,145  Antituberculosic
0,086  0,052  Glutathione S-transferase inhibitor
0,057  0,024  Antiviral (Herpesvirus 3, Human)
0,120  0,087  Vanilloid 1 agonist
0,037  0,005  Vanilloid 2 agonist
0,094  0,064  DNA directed RNA polymerase inhibitor
0,084  0,057  Antiviral (Trachoma)
0,143  0,116  Diabetic nephropathy treatment
0,132  0,106  Ca2+-transporting ATPase inhibitor
0,046  0,020  Estrogen receptor beta agonist
0,029  0,003  Telomerase stimulant
0,089  0,064  Glutamate release inhibitor
0,190  0,167  Metabolic disease treatment
0,087  0,064  Aminoacyl-tRNA synthetase inhibitor
0,104  0,081  Adenylate cyclase inhibitor
0,057  0,036  Adenine nucleotide translocase inhibitor
0,075  0,054  GABA aminotransferase inhibitor
0,127  0,108  UGT2B9 substrate
0,024  0,006  Antibiotic Anthracycline-like
0,030  0,012  Toll-Like receptor 4 agonist
0,038  0,022  Estrogen receptor alpha agonist
0,109  0,094  Antihyperlipoproteinemic
0,110  0,095  Bone formation stimulant
0,026  0,012  Dopamine D1 agonist
0,030  0,016  1,3-Beta-glucan synthase inhibitor
0,221  0,207  CYP2C19 inhibitor
0,049  0,035  Squalene epoxidase inhibitor
0,113  0,101  Papain-like protease (SARS coronavirus) inhibitor
0,132  0,120  Antiviral (Hepatitis C)
0,084  0,073  Breast cancer-resistant protein inhibitor
0,085  0,076  Butyrylcholinesterase inhibitor
0,056  0,046  Lipocortins synthesis agonist
0,105  0,096  Antiacne
0,141  0,131  Sepsis treatment
0,190  0,181  Angiogenesis inhibitor
0,085  0,076  Protein kinase C zeta inhibitor
0,139  0,131  Phospholipase C inhibitor
0,050  0,042  Carbonic anhydrase IX inhibitor
0,024  0,016  Adenosine A1 receptor agonist
0,023  0,015  GRP78 expression inhibitor
0,056  0,050  Carbonic anhydrase inhibitor
0,178  0,172  Transcription factor STAT inhibitor
0,083  0,078  MAO A inhibitor
0,123  0,118  Neuropathy treatment
0,031  0,026  Estrogen-related receptor beta antagonist
0,081  0,078  Actinic keratosis treatment
0,103  0,101  Contraceptive
0,103  0,100  Constipation treatment
0,010  0,008  Purinergic P2Y2 agonist
0,032  0,030  Protein kinase C beta I inhibitor
0,024  0,023  Uridine phosphorylase inhibitor
0,106  0,106  Antifungal (Pneumocystis)

